- 相關(guān)推薦
醫(yī)學(xué)專業(yè)論文參考文獻(xiàn)
從小學(xué)、初中、高中到大學(xué)乃至工作，大家都嘗試過寫論文吧，論文是指進(jìn)行各個學(xué)術(shù)領(lǐng)域的研究和描述學(xué)術(shù)研究成果的文章。那么你知道一篇好的論文該怎么寫嗎？以下是小編收集整理的醫(yī)學(xué)專業(yè)論文參考文獻(xiàn)，希望對大家有所幫助。
醫(yī)學(xué)論文參考文獻(xiàn)一：
[1]高松柏.國際嬰幼兒食品研究新動態(tài)[J].中國乳品工業(yè)，2007(4)：36-40.
[2]趙學(xué)偉.食品擠壓膨化機(jī)理研宄進(jìn)展[J].糧食加工，2010,35 (2) :59-65.
[3]丁小林.大豆食品的營養(yǎng)價值與功能特性[J].食品研宄與開發(fā)，2004,25,(6)：101.
[4]韓立德，蓋鈞鎰，張文明.大豆?fàn)I養(yǎng)成分研究現(xiàn)狀[J].種子，2003(5)： 58.
[5]夏劍秋，張毅方.大豆中主要營養(yǎng)成分和微量元素的功能作用[J].中國油脂，2007,3(1)：72.
[6]姜中航，嬰兒配方奶粉生產(chǎn)中部分應(yīng)用大豆分離蛋白的研宂[J].大豆科技，2009(2)：41-43.
[7]高連勝，李鐵紅，崔洪濱，等.適合嬰兒配方奶粉用蛋白的研宄[J].食品工業(yè)，2009(4)：52.
[8]張瑞巖.豆基嬰兒配方粉的研究[D].東北農(nóng)業(yè)大學(xué)，2009.
[9]張連慧.大豆分離蛋白在乳及乳制品中的應(yīng)用[J].食品安全導(dǎo)刊，2009(5)： 46.
[10]陳莉.無糖速溶速凝豆奶粉的研制[D].江南大學(xué)，2005.
[11]朱彥群，倪群.牛奶大豆雙蛋白營養(yǎng)酸奶的研究[J].食品研究與開發(fā)，2007,28(4) :110-111.
[12]高蟬，高連勝.大豆分離蛋白在嬰兒配方粉中的應(yīng)用研宄[J].中國乳業(yè).2008(3)56-58.
[13]汪之頊.葉黃素和玉米黃質(zhì)對視覺發(fā)育和健康的影響[J].國外醫(yī)學(xué)衛(wèi)生學(xué)分冊.2008(3)： 154-159.
[14]李忠海，李安平.嬰幼兒營養(yǎng)米粉配方的優(yōu)化設(shè)計[J].中南林學(xué)院學(xué)報，2001,21(1)：54-57.
[15]AnastaseH. Evaluation of rice flour modified by extrusion cooking [J]. Journal ofcereal Science, 2006(43) :38-46.
[16]MercedsB,ConsueloM,PerezO, etal. Varietal differences in properties of extrusioncooked rice flour[J]. Food Chemistry, 1986, 19(3)： 173-187.
醫(yī)學(xué)論文參考文獻(xiàn)二：
[1]陸紅梅.視疲勞中醫(yī)理論探討及用藥規(guī)律分析[D];揚州大學(xué)，2010.
[2]葉建東.視疲勞診斷、病因及其治療的研究進(jìn)展[J].中國療養(yǎng)醫(yī)學(xué)，2014,03)： 210-2.
[3]張仁.透刺為主治療視疲勞的臨床觀察[J].上海針灸雜志，2007,09)： 9-11.
[4]李尖.視屏顯示終端與視疲勞及潘光不正[J].臨床醫(yī)藥實踐，2006,08)：589-91.
[5]張秀云.新型飲食療法對2型糖尿病患者的干預(yù)效果[J].中華護(hù)理雜志，2004, 10)： 22-4.
[6]張廣琴.中青年視疲勞與視屏終端[J].大家健康(學(xué)術(shù)版)，2011,19)：16-7.
[7]陳麗君.利用傳統(tǒng)醫(yī)學(xué)經(jīng)絡(luò)調(diào)理法改善視疲勞的臨床觀察[D];北京中醫(yī)藥大學(xué)，2011.
[8]潘小云.加味六君子湯治療視疲勞40例療效觀察[J].浙江中醫(yī)雜志，2010,02)： 130.
[9]黃文剛.中藥熏蒸聯(lián)合眼部穴位按摩改善視疲勞癥狀的療效觀察[J].中國中醫(yī)眼科雜志，2014,04)： 251-4.
[10]Johnson E J. A biological role of lutein [J]. Food Rev Int,2004,20(1); 1-16.
[11]Christen W Q Liu S,Glynn R J,et al. Dietary carotenoids, vitamins C and E, and risk of cataract in women [J]. Arch Ophthalmol, 2008, 126(1)： 102-9.
[12]Bone R A,Landrum J T,Dixon Z,et al. Lutein and zeaxanthin in the eyes,serum and diet of human subjects [J]. Exp Eye Res, 2000,71(3)： 239-45.
醫(yī)學(xué)論文參考文獻(xiàn)三：
[1]程牛亮.生物化學(xué)[M].北京：高等教育出版社，2011:299-311.]
[2]毛羽揚.食鹽在烹飪調(diào)味中的作用[J].中國調(diào)味品，1999,5.
[3]巖瀨榮一.鹽及其化學(xué)[M].北京：輕工業(yè)出版社，1960:10-36.
[4]蘇敬.新修本草[M].群聯(lián)出版社，1955.
[5]金明宮.竹鹽的烤熔熏制法[J].中小企業(yè)科技，2003,7:019.
[6]潘進(jìn)富，張成霞.化學(xué)教育[M].1999,20 (6)：3-4.
[7]李衛(wèi)平.功能性保健食鹽的開發(fā)研究[J].海湖鹽科技資料，2000(8)：1-6.
[8]王琦.王琦方藥應(yīng)用31論[M].2012:250-267.
[9]陳敏章，邵丙楊.中華內(nèi)科學(xué)[M],北京：人民衛(wèi)生出版社，2006:2477-2481.
[10]高欽穎.韓國仁山竹鹽治療胃病15例[J].陜西中醫(yī)，1994,15(7)：298.
[11]美國NKF-K/DOQI工作組.慢性腎臟病及透析的臨床實踐指南[M].北京：人民衛(wèi)生出版社，2003(1).
[12]郭義敏，劉穎，陳歷明.近端腎小管碳酸氫根重吸收的分子機(jī)制及代謝性酸中毒[J].生理學(xué)報，2014,66(4)： 398~414.
[13]Moon, et al. The Intrinsic Antimicrobial Activity of Bamboo Salt against Salmonella enteritidis[J]. Molecular and Cellular Toxicology, 2010,6(1)： 109-109.
醫(yī)學(xué)論文參考文獻(xiàn)
[1]Weaver A., da Silva A. G, Nuttall R. K.，et al. An elevated matrix metalloproteinase(MMP) in an animal model of multiple sclerosis is protective by affecting Thl/Th2polarization. The FASEB journal. 2005. 19(12): p. 1668-1670.
[2]Venteo L_，Bourlet T” Renois F” et al. Enterovirus-related activation of thecardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis.European heart journal. 2010. 31(6): p. 728-736.
[3]Rose N. R. The adjuvant effect in infection and autoimmunity. Clinical reviews inallergy & immunology. 2008. 34(3): p. 279-282.
[4]陳瑞珍，解玉泉.病毒性心肌炎向擴(kuò)張型心肌病演變的免疫學(xué)機(jī)制.診斷學(xué)理論與實踐-2012. 10(5): p. 414-417.
[5]Camporeale A., Marino F” Papageorgiou A.，et al. STAT3 activity is necessary andsufficient for the development of immune “ mediated myocarditis in mice andpromotes progression to dilated cardiomyopathy. EMBO molecular medicine. 2013.5(4): p. 572-590.
[6]Zhu J.,Paul W. E. CD4 T cells: fates, functions, and faults. Blood. 2008. 112(5): p.1557-1569.
[7]Korn T.，Bettelli E?，Oukka M.，et al. IL-17 and Thl7 Cells. Annual review ofimmunology. 2009. 27: p. 485-517.
[8]Yu Y” Liu Y-，Shi F.-D., et al. Cutting edge: leptin-induced RORyt expression in CD4+T cells promotes Thl7 responses in systemic lupus erythematosus. The Journal ofImmunology. 2013. 190(7): p. 3054-3058.
[9]van Bruggen N.,Ouyang W. Thl7 Cells at the Crossroads of Autoimmunity,Inflammation, and Atherosclerosis. Immunity. 2014. 40(1): p. 10-12.
[10]Annnn2:iatoF., Cosmi L., Santarlasci V.，et al. Phenotypic and functional features ofhuman Thl7 cells. The Journal of experimental medicine. 2007. 204(8): p. 1849-1861.
[11]ShahraraS.，Huang Q.，Mandelin II A. M.，et al. TH-17 cells in rheumatoid arthritis.Arthritis Research and Therapy. 2008. 10(4): p. R93.
[12]KomiyamaY.，Nakae S.，Matsuki T_，et al. IL-17 plays an important role in thedevelopment of experimental autoimmune encephalomyelitis. The Journal ofImmunology. 2006. 177(1): p. 566-573.
[13]Bettelli E” Carrier Y?，Gao W，et al. Reciprocal developmental pathways for thegeneration of pathogenic effector TH17 and regulatory T cells. Nature. 2006.441(7090): p. 235-238.
[14]VeldhoenM.，Hocking R. J.，Atkins C. J.，et al. TGFp in the context of aninflammatory cytokine milieu supports de novo differentiation of IL-17-producing Tcells. Immunity. 2006. 24(2): p. 179-189.
[15]ManganP. R., Harrington L. E.，OQuinn D. B.，et al. Transforming growth factor-pinduces development of the TH17 lineage. Nature. 2006. 441(7090): p. 231-234.
[16]AkimzhanovA. M.，Yang X. 0.,Dong C. Chromatin remodeling of interleukin-17(IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation.Journal of biological chemistry. 2007. 282(9): p. 5969-5972.
[17]NurievaR” Yang X. 0” Martinez G，et al. Essential autocrine regulation by IL-21 inthe generation of inflammatory T cells. Nature. 2007. 448(7152): p. 480-483.
[18]Yang L，Anderson D. E.，Baecher-Allan C.，et al. IL-21 and TGF-&bgr; are requiredfor differentiation of human TH17 cells. Nature. 2008.454(7202): p. 350-352.
[19]TrinchieriG，Pflanz S.,Kastelein R. A. The IL-12 family of heterodimeric cytokines:new players in the regulation of T cell responses. Immunity. 2003. 19(5): p. 641-644.
[20]Zhou L，Ivanov I. I，Spolski R?，et al. IL?6 programs TH-17 cell differentiation bypromoting sequential engagement of the IL-21 and IL-23 pathways. Natureimmunology. 2007. 8(9): p. 967-974.
[21]AggarwalS” Ghilardi N., Xie M.-H.，et al. Interleukin-23 promotes a distinct CD4 Tcell activation state characterized by the production of interleukin-17. Journal ofBiological Chemistry. 2003. 278(3): p. 1910-1914.
[22]Harrington L. E., Hatton R. D.，Mangan P. R.，et al. Interleukin 17—producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nature immunology. 2005. 6(11): p. 1123-1132.
[23]Yang X. 0., Panopoulos A. D.，Nurieva R.，et al. STAT3 regulates cytokine-medlatedgeneration of inflammatory helper T cells. Journal of Biological Chemistry. 2007.282(13): p. 9358-9363.
[24]LaurenceA.，Tato C. M.，Davidson T. S?，et al. Interleukin-2 signaling via STAT5constrains T helper 17 cell generation. Immunity. 2007. 26(3): p. 371-381.
[25]EberlG，Marmon S.，Sunshine M.-J.，et al. An essential function for the nuclearreceptor RORyt in the generation of fetal lymphoid tissue inducer cells. Natureimmunology. 2004. 5(1): p. 64-73.
[26]Yang X. 0” Pappu B. P.，Nurieva R., et al. T helper 17 lineage differentiation isprogrammed by orphan nuclear receptors RORa and RORy. Immunity. 2008. 28(1): p.29-39.
[27]IvanovI. I.，McKenzie B. S.，Zhou L.，et al. The Orphan Nuclear Receptor RORytDirects the Differentiation Program of Proinflammatory IL-17< sup>+ T HelperCells. Cell. 2006. 126(6): p. 1121-1133.
[28]QingK.，Weifeng W” Fan Y?，et al. Distinct different expression of Thl7 and Th9 cellsin coxsackie virus B3-induced mice viral myocarditis. Wol J. 2011. 8: p. 267.
[29]Jiang N.，Liao W”Kuang X. Effects of emodin on IL-23/IL-17 inflammatory axis，Thl7 cells and viral replication in mice with viral myocarditis. Nan Fang Y Ke DaXue Xue Bao. 2014. 34(3): p. 373-378.
[30]Yang F.，Wu W.-F.，Yan Y.-L.，et al. Expression of il-23/thl7 pathway in a murinemodel of coxsackie virus b3-induced viral myocarditis. Virology journal. 2011. 8(1): p.301.
[31]FanY” Weifeng W., Yuluan Y” et al. Treatment with a neutralizing anti-murineinterleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditisreduces myocardium inflammation. Virol J. 2011. 8(1): p.17.
[32]Yu M.5 Hu J” Zhu M. X.，et al. Cardiac fibroblasts recruit Thl7 cells infiltration intomyocardium by secreting CCL20 in CVB3-induced acute viral myocarditis. CellPhysiol Biochem. 2013. 32(5): p, 1437-1450.
[33]XieY.，Chen R.，Zhang X.，et al. The role of Thl7 cells and regulatory T cells inCoxsackievirus B3-induced myocarditis. Virology. 2011. 421(1): p. 78-84.
[34]YuanJ., Yu M., Lin Q.-W., et al. Thl7 cells contribute to viral replication incoxsackievirus B3-induced acute viral myocarditis. The Journal of Immunology. 2010.185(7): p. 4004-4010.
[35]YuanJ.，Cao A.-L., Yu M.，et al. Thl7 cells facilitate the humoral immune response inpatients with acute viral myocarditis. Journal of clinical immunology. 2010. 30(2): p.226-234.
[36]Yuan J” Yu M.，Lin Q.-W., et al. Neutralization of IL-17 inhibits the production ofanti-ANT autoantibodies in CVB3-induced acute viral myocarditis. Internationalimmunopharmacology. 2010.10(3): p. 272-276.
[37]Liu Y?，Zhu H?，Su Z.，et al. IL-17 contributes to cardiac fibrosis followingexperimental autoimmune myocarditis by a PKCbeta/Erkl/2/NF-kappaB_dependentsignaling pathway. Int Immunol. 2012. 24(10): p. 605-612.
[38]BaldevianoG C., Barin J. G，Talor M. V” et al. Interleukin-17A is dispensable formyocarditis but essential for the progression to dilated cardiomyopathy. Circulationresearch. 2010. 106(10): p. 1646-1655.
【醫(yī)學(xué)專業(yè)論文參考文獻(xiàn)】相關(guān)文章：
物流論文參考文獻(xiàn)03-30
mysql論文參考文獻(xiàn)03-03
數(shù)學(xué)教學(xué)的論文參考文獻(xiàn)06-14
體育專業(yè)論文參考文獻(xiàn)03-09
數(shù)學(xué)教學(xué)論文參考文獻(xiàn)04-03
科技論文參考文獻(xiàn)格式04-25
web論文參考文獻(xiàn)參考04-25
論文參考文獻(xiàn)的基本格式11-18